Accustem Science Stock Price, News & Analysis
Company Description
Accustem Science (OTC: ACMSY) is a publicly traded diagnostics & research company in the Healthcare sector.
ACMSY stock has declined 18.8% over the past year.
This page provides a comprehensive overview of ACMSY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Accustem Science (ACMSY) stock. Over the past 12 months, the stock has lost 18.8%.
Latest News
Accustem Science has 6 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include private placement, management. View all ACMSY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ACMSY Company Profile & Sector Positioning
Accustem Science (ACMSY) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ACMSY often look at related companies in the same sector, including bioAffinity Tech (BIAFW), Inotiv Inc (NOTV), Precipio Inc (PRPO), Prophase Labs Inc (PRPH), and Ispecimen Inc. (ISPC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ACMSY's relative position within its industry.